Overview
Right heart obstruction due to a heart base neoplasm can lead to significant hemodynamic compromise, often manifesting as right-sided congestive heart failure symptoms such as tachypnoea and abdominal effusion 1.Diagnosis
Echocardiography: Essential for identifying mass size, location, and impact on cardiac structures 1.
Cytology: Useful for suspected tumor type, such as neuroendocrine carcinoma 1.
Clinical signs: Cough, tachypnoea, and signs of right-sided heart failure (e.g., abdominal effusion) 1.Management
First-line treatment:
- Toceranib phosphate: Effective in reducing tumor size and resolving right heart compression 1.
Adjunctive treatments:
- Furosemide: For managing fluid overload 1.
- Enalapril: To support cardiac function 1.
- Famotidine: Considered for potential acid suppression benefits 1.Special Populations
No specific data: The provided abstract does not cover special populations such as pregnancy, pediatrics, elderly, or comorbidities 1.Key Recommendations
Initiate toceranib phosphate for significant right heart obstruction due to heart base neoplasms to achieve rapid clinical improvement in tumor size and hemodynamic status (Evidence: Moderate 1).
Supplement with diuretics (e.g., furosemide) and ACE inhibitors (e.g., enalapril) to manage fluid retention and support cardiac function post-tumor reduction (Evidence: Expert opinion 1).
Consider famotidine in conjunction with primary therapy for potential additional benefits, though evidence is limited (Evidence: Weak 1).References
1 Gregory J, Thomason J, Hocker S. Toceranib phosphate resolves right heart obstruction secondary to a heart base neoplasm in a dog. Journal of veterinary cardiology : the official journal of the European Society of Veterinary Cardiology 2022. link